Emoksi optician drops Ch. 5ml 1%-cap vial.

Description

Composition
Active substance:
1 ml of solution contains: metiletilpiridinola hydrochloride – 10 mg.
Excipients:
Sodium sulfite (anhydrous sodium sulfite), sodium benzoate, potassium dihydrogenphosphate (potassium dihydrogen phosphate), sodium hydrogen phosphate dodecahydrate (sodium phosphate dibasic 12-water), methylcellulose, water for injection.
Product form:
1% eye drops. 5 or 10 ml vials in a colorless glass. 5 ml or 10 ml vials with a nozzle and a dosing cap, a screw made of plastic. 1 bottle of plastic with instructions for use placed in a pile of cardboard. 1 glass vial with instructions for use and the cap is placed in a dropper pack of cardboard or without a dropper cap.
Contraindications
Hypersensitivity. Pregnancy. Lactation (breastfeeding), children up to 18 years.
Dosage
0.01
Indications
Used in adults in the following diseases and conditions: hemorrhages in the anterior chamber (treatment); hemorrhages in the sclera in elderly patients (treatment and prevention); inflammation and corneal burns (treatment and prevention); complications of myopia (treatment); Protection of the cornea (contact lens).
Interaction with other drugs
The drug should not be mixed with other drugs.
Overdose
Not installed.
pharmachologic effect
Pharmacological group:
Anti-oxidant agent.
Pharmacodynamics:
The antioxidant (a drug that prevents lipid peroxidation of cell membranes) having angioprotektornoy (increase resistance vessels), antiplatelet (preventing platelet agglutination) and antihypoxic (increases tissue resistance to lack of oxygen) activity. It reduces the permeability of capillaries and strengthens the vascular wall (angioprotector). Decreases blood viscosity and aggregation of platelets (antiplatelet agent). The inhibitor of free radical processes, has a membrane stabilizing effect. Retinoprotektornymi has properties to protect the retina and other eye tissues from the damaging effect of high intensity light. It promotes the resorption of intraocular hemorrhages, reduces clotting, improves eye. Stimulates the reparative processes in the cornea (including in the early postoperative period and postranevom).
Pharmacokinetics:
Quickly into the organs and tissues, where it is deposition and metabolism. In ocular tissue concentration is higher than in the blood. Detected 5 metabolites and conjugated represented dealkylated product conversion. The metabolites are excreted by the kidneys. The significant quantities detected in the liver of 2-ethyl-6-methyl-3-hydroxypyridin-phosphate.
Pregnancy and breast-feeding
Contraindicated.
Conditions of supply of pharmacies
On prescription.
side effects
Burning sensation, itching, transient hyperemia, rarely – local allergic reaction.
special instructions
If necessary, the simultaneous use of other eye drop formulation was instilled latest after complete absorption of preceding droplets (no less than 10-15 minutes).
Storage conditions
In the dark place at a temperature not higher than 25 ° C. Keep out of the reach of children.
Dosing and Administration
The drug is instilled into the conjunctival sac 1-2 drops 2-3 times a day. The course of treatment 3-30 days. If necessary and well tolerated treatment can be extended to 6 months and can be repeated 2-3 times a year.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist